Oxford BioDynamics Plc (AIM:OBD)
London · Delayed Price · Currency is GBP · Price in GBX 0.1400
+0.0150 (12.00%)
Jul 24, 2026, 4:21 PM GMT
Oxford BioDynamics Income Statement
Financials in millions GBP. Fiscal year is October - September.
Millions GBP. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
| 1.2 | 1.1 | 0.64 | 0.51 | 0.15 | 0.34 | |
Revenue Growth (YoY) | 9.13% | 72.17% | 24.71% | 231.17% | -54.84% | -25.22% |
Cost of Revenue | 0.64 | 0.57 | 0.35 | 0.24 | 0.04 | - |
Gross Profit | 0.56 | 0.52 | 0.29 | 0.27 | 0.12 | 0.34 |
Selling, General & Admin | 8.58 | 9.48 | 10.49 | 9.15 | 7.33 | 5.87 |
Depreciation & Amortization Expenses | 1.15 | 1.2 | 1.47 | 1.36 | 1.21 | 1.09 |
Research & Development | 0.42 | 0.62 | 0.81 | 0.76 | 0.53 | 0.9 |
Other Operating Expenses | 0.29 | 0.3 | 0.42 | -0.83 | -0.35 | -0 |
Total Operating Expenses | 10.44 | 11.6 | 13.18 | 10.43 | 8.72 | 7.85 |
Operating Income | -9.88 | -11.07 | -12.89 | -10.17 | -8.6 | -7.51 |
Interest Income | 0.06 | 0.06 | 0.11 | 0.1 | 0.13 | 0.03 |
Interest Expense | -0.29 | -0.42 | -0.52 | -0.21 | -0.2 | -0.15 |
Other Non-Operating Income (Expense) | - | 0.01 | 1.35 | -1.13 | 1.1 | - |
Total Non-Operating Income (Expense) | -0.23 | -0.35 | 0.94 | -1.24 | 1.03 | -0.12 |
Pretax Income | -10.11 | -11.42 | -11.96 | -11.41 | -7.57 | -7.63 |
Provision for Income Taxes | -0.24 | -0.27 | -0.39 | -0.59 | -0.86 | -0.95 |
Net Income | -9.87 | -11.15 | -11.57 | -10.83 | -6.71 | -6.68 |
Net Income to Common | -9.87 | -11.15 | -11.57 | -10.83 | -6.71 | -6.68 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 2,864 | 1,387 | 256 | 147 | 100 | 93 |
Shares Outstanding (Diluted) | 2,864 | 1,387 | 256 | 147 | 100 | 93 |
Shares Change (YoY) | 106.45% | 442.40% | 73.40% | 47.92% | 7.72% | - |
EPS (Basic) | -0.00 | -0.01 | -0.04 | -0.07 | -0.07 | -0.07 |
EPS (Diluted) | -0.00 | -0.01 | -0.04 | -0.07 | -0.07 | -0.07 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | -7.2 | -7.59 | -10.25 | -8.54 | -5.54 | -8.61 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -0.00 | -0.01 | -0.04 | -0.06 | -0.06 | -0.09 |
Gross Margin | 46.69% | 47.67% | 45.44% | 52.16% | 75.32% | 100.00% |
Operating Margin | -826.69% | -1011.32% | -2027.36% | -1993.73% | -5585.06% | -2202.93% |
Profit Margin | -825.61% | -1018.54% | -1818.71% | -2122.75% | -4357.14% | -1959.53% |
FCF Margin | -602.76% | -693.15% | -1611.95% | -1675.29% | -3597.40% | -2525.22% |
EBITDA | -8.73 | -9.88 | -11.43 | -8.81 | -7.39 | -6.42 |
EBITDA Margin | -730.21% | -901.83% | -1796.86% | -1727.65% | -4797.40% | -1883.87% |
EBIT | -9.88 | -11.07 | -12.89 | -10.17 | -8.6 | -7.51 |
EBIT Margin | -826.69% | -1011.32% | -2027.36% | -1993.73% | -5585.06% | -2202.93% |
Effective Tax Rate | 2.41% | 2.36% | 3.25% | 5.13% | 11.33% | 12.41% |